Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolongation of Contact Lens Comfortable Wear Duration by CLM2 Topical Gel
NCT03994406Phase 2Completed
- Start
- Jun 2019
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Contact lens discomfort (CLD) comparing CLM2 Topical Gel with Placebo Topical Gel (2 arms). Primary endpoints: Hours of continuous comfortable contact lens wear at 21 days, Contact Lens Questionnaire-8 at 21 days and 2 more. Started Jun 2019; status: completed.
02
Drugs
clomethiazole
03
Conditions
Contact lens discomfort (CLD)
Beyond the preview
Go deeper on NCT03994406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03994406.